Medical/Pharmaceuticals

Gerresheimer and Merck Transform Primary Packaging into Digital Twins

DÜSSELDORF, Germany, Oct. 27, 2022 /PRNewswire/ -- Gerresheimer AG, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmetics and Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure tr...

2022-10-27 16:50 2005

Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is today pleased to announce that it has been awarded Australian Company of the Year in the 2022 AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards, held today at t...

2022-10-27 10:23 2783

DR. FAIKA KHAN CEO OF CITY DOCTOR PVT. LTD. AND MR ALI J HASHMAT CEO OF CURE PARTNERS PVT. LTD. ANNOUNCEMENT OF FULL ACQUISITION OF "THE MEDICAL LABORATORY PVT. LTD." DBA ZEENAT LABORATORIES

NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Dr Faika Khan CEO of CITY DOCTOR PVT. LTD. andMr. Ali J Hashmat of CURE PARTNERS PVT. LTD. announced 100% acquisition of"The Medical laboratory Pvt. Ltd." Doing Businesses as (DBA) "ZEENAT LAB", one of the most renowned lab with a history of over 50 plus ye...

2022-10-27 10:19 1985

SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM'S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES

SUZHOU,China, Oct. 27, 2022 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHARM, Stock code: 1875.HK) has recently received a GMP compliance inspection report approved by aQualified Person ("QP") in the European Union ("EU") in respect of the manufacturing facilities and asso...

2022-10-27 08:00 2179

JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies

* Initial focus on accelerating development of 2seventy's MAGE-A4 program in solid tumors inChina SHANGHAI, China and CAMBRIDGE, Mass., Oct. 27, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and comme...

2022-10-27 07:53 3344

Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of TheUniversity of Queensland (UQ), to develop a radiolabelled molecule targeting an im...

2022-10-27 06:44 2285

Texas Cardiac Arrhythmia Institute physician led international workshop on cardiac arrhythmias

AUSTIN, Texas, Oct. 26, 2022 /PRNewswire/ -- The executive medical director of theTexas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center  recently ledVenice Arrhythmias 2022, a biennial international workshop on cardiac arrhythmias held inVenice, Italy from October 13 to October 1...

2022-10-26 22:08 2405

OncoK9®, the Pioneering Blood-Based Early Cancer Detection Test for Dogs, Now Available in Asia Through Asia Veterinary Diagnostics

In the first expansion of access beyond North America, the OncoK9® test from PetDx® is now available inHong Kong, Singapore, Malaysia, South Korea, and Cambodia at veterinary clinics served by Asia Veterinary Diagnostics. SAN DIEGO, Oct. 26, 2022 /PRNewswire/ -- PetDx® – The Liquid Biopsy Compan...

2022-10-26 21:00 1872

Ascletis Announces U.S. IND Filing of Oral Antiviral ASC10 for Monkeypox Indication

--ASC10 has two indications: monkeypox and SARS-CoV-2 virus infections. The Investigational New Drug (IND) application of the latter was approved by the U.S. Food and Drug Administration (FDA) inAugust 2022 and Phase Ib clinical trial in COVID-19 patients is underway in the U.S. --Preclinical st...

2022-10-26 20:10 2224

First satellite bioanalytical lab offers fastest option for PBMC processing in Australian clinical trials

THEBARTON, Australia, Oct. 26, 2022 /PRNewswire/ -- On 09 September 2022, Australia welcomed its first bioanalytical laboratory inside a Phase 1 clinical unit. Agilex Biolabs, Australia's largest bioanalytical laboratory, has established its first satellite processing unit on the fifth floor o...

2022-10-26 17:00 905

Mahidol University, the Top University in Thailand, Has Officially Adopted Jolly Good's Medical VR

Developing and Demonstrating VR of Infectious Disease Education in Collaboration with Juntendo University Approximately 15% of All Deaths in Thailand Are Caused by Infectious Diseases TOKYO, Oct. 26, 2022 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to...

2022-10-26 13:00 2455

Singapore to host the 7th World One Health Congress

Leading global scientists and policymakers will exchange learnings to promote multi-sectoral collaboration to address complex global health challenges SINGAPORE, Oct. 26, 2022 /PRNewswire/ -- The 7th World One Health Congress (WOHC), the world's premier event to advance the One Health agenda, wil...

2022-10-26 12:03 2038

Mentice and Acandis GmbH announce a 3-year agreement for Mentice Ankyras clinical support software solutions at a value of 8.9mSEK

Sweden-Gothenburg and Germany-Pforzheim, October 25, 2022 ( https://news.cision.com/mentice-ab).  GOTHENBURG, Sweden, Oct. 25, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzh...

2022-10-25 23:23 1972

Metabolon Advances the Understanding of Inflammation and Inflammatory Response with New Oxysterols Targeted Panel

The new targeted metabolomics panel provides absolute quantitation for important bioactive intermediaries of inflammation and disease pathogenesis MORRISVILLE, N.C., Oct. 25, 2022 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of...

2022-10-25 20:03 2071

Clarivate Identifies Seven Innovators in New RNA Technology Companies to Watch Report

Report analyzes benefits, financing, R&D activity and more to reveal emerging standouts in medical science United States and Mainland China at the forefront of RNA technology advancement LONDON, Oct. 25, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted inform...

2022-10-25 15:19 1732

BioCell Technology Expands Global Presence and Trust with Prestigious Halal Certification

BioCell Collagen®, the company's flagship ingredient, is now halal-certified by the Islamic Information Documentation and Certification GmbH (IIDC), an accreditation accepted in nearly all Islamic countries IRVINE, Calif., Oct. 25, 2022 /PRNewswire/ -- BioCell Collagen®, a clinically-studied die...

2022-10-25 12:00 2108

MiRXES collaborates with Plug and Play to launch Southeast Asia's first science-backed commercialization engine and validator program

MiRXES Translator Program will accelerate revenue growth of start-ups and importantly, adoption of preventive healthcare solutions globally SINGAPORE, Oct. 25, 2022 /PRNewswire/ -- MiRXES , a Singapore-headquartered biotechnology company focused on saving lives and improving...

2022-10-25 11:50 2498

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

GENEVA, Oct. 25, 2022 /PRNewswire/ -- Following our communication last  week "MedAlliance to be acquired by Cordis",MedAlliance is pleased to make the following announcement:  SELUTION SLR™, MedAlliance's novel sirolimus...

2022-10-25 08:00 2459

T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness

* Preclinical data showing how ERA™, eTurna™ technologies turbocharge T-cell therapies presented at New Frontiers of RNA Nanotherapeutics meeting today * ERA™ boosts CAR T-cell efficacy by overcoming T-cell exhaustion that inhibits cancer cures * eTurna™ delivery platform delivers more healt...

2022-10-24 23:30 2655

deCODE genetics publishes multiomics study of nonalcoholic fatty liver disease

Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD). REYKJAVIK, Iceland, Oct. 24, 2022 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, publish t...

2022-10-24 23:00 2707
1 ... 115116117118119120121 ... 382